As of 2025-05-18, the Fair Value of Tianda Pharmaceuticals Ltd (455.HK) is -0.14 HKD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.16 HKD, the upside of Tianda Pharmaceuticals Ltd is -192.08%.
With the market price of 0.16 HKD and our fair value calculation, Tianda Pharmaceuticals Ltd (455.HK) is not a good investment. Investing in 455.HK stocks now will result in a potential loss of 192.08%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-03-31 | 2022-03-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -27.14 | -19.77 | -40.98 | -24.16 | -61.37 | -34.68 |
| YoY growth | -963.57% | 27.16% | -107.26% | 41.05% | -154.07% | -231.34% |
| Market Cap (mil) | 333.26 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | -231.34% |
| TTM earnings | -61.37 |